Archives
-
Lipid-Like Nanoassemblies for Secreted ACE2 mRNA
2026-08-21
The reference study developed lipid-like nanoassemblies that protected in-vitro-transcribed mRNA, enabled high systemic translation, and produced secreted truncated ACE2 decoys with SARS-CoV-2 receptor-blocking activity. Its main contribution is a preclinical delivery strategy that connects combinatorial lipid design with transient production of an antiviral protein mimic.
-
Synthetic Receptor Microglia for Alzheimer’s Therapy
2026-08-20
Shao and colleagues developed a synthetic efferocytic receptor that redirects microglia toward amyloid-β clearance while preserving anti-inflammatory signaling. Delivered as mRNA lipid nanoparticles, the receptor improved amyloid handling, reduced inflammation and synapse loss, and improved behavioral outcomes in an Alzheimer’s disease mouse model.
-
2-Thio-dCTP and the Next Era of DNA Precision
2026-08-20
A mechanistic and translational guide to using 2-Thio-dCTP as a compact DNA perturbation tool, with practical strategies inspired by new SCP4 chromosome-stability findings.
-
Fluoroalkane Polymers for mRNA Cancer Vaccines
2026-08-19
Li and colleagues developed fluoroalkane-grafted polyethylenimine (F-PEI) as a simple cationic carrier that combines mRNA protection and intracellular delivery with deliberate TLR4-mediated immune stimulation. In mouse models, F-PEI–mRNA vaccines improved dendritic-cell activation and antigen presentation, delayed B16-OVA melanoma, and, with checkpoint blockade, suppressed MC38 tumors and recurrence.
-
Pseudo-UTP for Better mRNA Synthesis Workflows
2026-08-19
Learn how Pseudo-UTP supports pseudouridine-containing RNA production, from in vitro transcription screening to translation and stability assays. This practical guide connects nucleotide substitution decisions with vaccine, gene therapy, and troubleshooting workflows while distinguishing product-level benefits from evidence in a preclinical vaccine study.
-
Deferasirox Pharmacokinetics and Clinical Evidence
2026-08-18
Galanello, Campus, and Origa synthesize pharmacokinetic, pharmacodynamic, efficacy, and safety evidence for deferasirox across transfusion-dependent anemias. The review’s central contribution is to connect oral chelation, iron-burden biology, adherence, and monitoring requirements while showing why treatment response varies between patient groups.
-
Firefly Luciferase mRNA: LNP Assay Guide
2026-08-18
Build sensitive reporter assays with Cap1-capped, 5-moUTP modified mRNA while preserving a practical path from cell-based screening to in vivo imaging. This guide connects transcript handling, transfection, LNP formulation, normalization, and troubleshooting to evidence-based assay design.
-
Firefly Luciferase mRNA: Workflow & Optimization
2026-08-17
Firefly Luciferase mRNA (ARCA, 5-moUTP) provides a sensitive, transient readout for transfection, gene expression, cell viability, and delivery studies. This practical guide connects reporter assay design with emerging nanoparticle workflows, including lung-directed formulations and stability testing.
-
Betaine-Loaded LNPs Improve mRNA Delivery After Freezing
2026-08-17
The reference study shows that freeze concentration can be used not only to protect lipid nanoparticles (LNPs), but also to drive betaine incorporation into them during freeze–thaw processing. The incorporated betaine improves endosomal escape and mRNA delivery, producing stronger reporter expression and immune responses in mouse studies.
-
Methicillin Sodium Salt for MSSA Research
2026-08-16
Methicillin sodium salt provides a practical phenotypic benchmark for MSSA susceptibility, cell-wall biology, and resistance-aware assay design. This guide shows how to build reproducible dilution workflows, distinguish true MRSA resistance from technical failure, and translate results without overstating clinical relevance.
-
Firefly Luciferase mRNA Workflow Guide
2026-08-15
Build sensitive, reproducible reporter assays with Cap1-capped, 5-moUTP modified mRNA for delivery, translation, viability, and imaging studies. The workflow also shows how PEG-lipid selection can change LNP performance, helping researchers separate transcript quality from delivery effects.
-
ARCA EGFP mRNA: Assay Design Beyond Fluorescence
2026-08-14
ARCA EGFP mRNA (5-moUTP) can serve as more than a fluorescent reporter: it is a practical calibration tool for separating delivery, translation, and cell-state effects. This article connects reporter assay design with evidence on lipid nanoparticle structure, delivery route, and inflammatory biology.
-
Valemetostat (DS-3201): From EZH2 Biology to Translation
2026-08-14
Valemetostat (DS-3201) offers a translational framework for studying PRC2-dependent lymphoma biology through potent EZH2 inhibition, mutant-sensitive activity, and context-aware epigenetic research. This thought-leadership article connects molecular pharmacology with biomarker strategy, experimental workflow design, adoptive cell therapy research, and disciplined cross-domain target validation.
-
Pseudo-UTP Workflow for Better mRNA Synthesis
2026-08-13
Pseudo-UTP gives researchers a practical route to test pseudouridine-containing RNA for improved persistence, translation, and immunogenicity control. This workflow connects reagent handling and in vitro transcription optimization with the assay architecture used in current Omicron mRNA vaccine research.
-
Resveratrol SIRT1 Assays: Neuroprotection Workflow
2026-08-13
Build a pathway-resolved Resveratrol neuroprotection assay around SIRT1, mitochondrial biogenesis, and apoptosis rather than relying on a single viability endpoint. This workflow translates findings from prion-stressed N2a cells into practical dose selection, controls, readouts, and troubleshooting decisions.